| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;44:72.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Obstetrics and Gynecology and Physiology, Virginia Commonwealth University Medical Center, Richmond.
Correspondence to Dr. Scott W. Walsh, Department of Obstetrics and Gynecology, PO Box 980034, Virginia Commonwealth University Medical Center, Richmond, VA 23298-0034. E-mail swwalsh{at}vcu.edu
| Abstract |
|---|
|
|
|---|
Key Words: neutrophils preeclampsia interleukins cell adhesion molecules endothelium adipose tissue
| Introduction |
|---|
|
|
|---|
Preeclampsia is a hypertensive disorder of human pregnancy and a leading cause of maternal and fetal morbidity and mortality.3 Clinically, it is diagnosed as maternal hypertension with proteinuria. Pathological edema is usually present. The pathophysiology of preeclampsia is associated with neutrophil activation,4 oxidative stress,5,6 and endothelial cell dysfunction.7 Greer et al first reported that neutrophils were activated by measuring a significant increase in neutrophil elastase in the maternal circulation.8 Subsequently, Tsukimori et al and others reported a significant increase in superoxide production by neutrophils obtained from preeclamptic women.911 Barden et al reported upregulation of neutrophil ß-integrins.12 Neutrophil activation likely occurs as they circulate through the intervillous space and are exposed to oxidized lipids secreted by the placenta.5,13,14 Although neutrophils are activated, their role in the pathogenesis of preeclampsia is not known. One role could be to act as cellular carriers of oxidative stress from the placenta to the maternal circulation by adhering and infiltrating maternal systemic vasculature.
Neutrophil infiltration into vascular tissue requires vascular expression of a chemotactic agent to attract neutrophils, endothelial expression of adhesion molecules to bind neutrophils to the endothelium, as well as neutrophil activation. To study if neutrophils adhere to endothelium and infiltrate systemic resistance-sized vessels in women with preeclampsia, we used immunohistochemistry to evaluate: (1) vascular smooth muscle expression of interleukin-8 (IL-8), a potent neutrophil chemotactic agent and activator of neutrophils; (2) endothelial expression of intercellular adhesion molecule-1 (ICAM-1), an adhesion molecule that binds ß-integrins on the neutrophil surface, causing them to adhere and flatten onto the endothelium before infiltration; and (3) neutrophil activation and infiltration into systemic vascular tissue. We evaluated neutrophils in preference of other leukocytes because: (1) they are the most abundant of the leukocytes; (2) their numbers increase in pregnancy;3 (3) their numbers further increase in preeclampsia;15 and (4) they produce toxic substances (thromboxane, ROS, myeloperoxidase, and tumor necrosis factor-
),1,16 which could be responsible for vasoconstriction and vascular cell dysfunction. We hypothesized that in women with preeclampsia, there would be increased expression of vascular smooth muscle IL-8 and endothelial ICAM-1 coincident with infiltration of neutrophils into maternal systemic vascular tissue.
| Methods |
|---|
|
|
|---|
Subcutaneous fat biopsy samples were used because subcutaneous fat is a highly vascularized tissue representative of the systemic vasculature and it is easily obtained at the time of surgery. Vessels of subcutaneous fat were stained for IL-8, ICAM-1, and CD66b, a granulocyte-specific antigen. CD66b is upregulated and secreted on granulocyte activation. CD66b staining primarily represents neutrophils because they comprise 96% of the granulocyte population.
Details on patients, fat collection, immunohistochemistry, data analysis, and statistical analysis are available in an online supplement at http://www.hypertensionaha.org.
| Results |
|---|
|
|
|---|
|
Results for IL-8, ICAM-1, and CD66b are shown in Figure 1. Staining scores and OD measurements for IL-8 and CD66b were significantly greater for patients with preeclampsia than for normal pregnant or normal nonpregnant patients. There was little or no staining for IL-8 or CD66b in vessels of normal nonpregnant or normal pregnant patients. In contrast, ICAM-1 was expressed in vessels of all groups, with normal pregnant scores and OD significantly lower than preeclamptic or normal nonpregnant scores.
|
Staining results for IL-8 are shown in Figure 2. Normal nonpregnant patients had little or no vascular staining (Figure 2a), whereas normal pregnant patients had light staining, including light staining in vascular smooth muscle (Figure 2b). Serial sections of a patient with preeclampsia are shown in Figure 2c to 2f, with staining for IgG as negative control, factor VIII to identify endothelial cells, IL-8, and
-smooth muscle actin to identify vascular smooth muscle cells. In contrast to normal nonpregnant and normal pregnant patients, patients with preeclampsia had intense IL-8 staining in endothelium, as well as intense IL-8 staining in vascular smooth muscle. Figure 2g shows another example of intense IL-8 staining in vascular smooth muscle verified by staining for
-smooth muscle actin in a serial section (Figure 2h).
|
Staining results for ICAM-1 are shown in Figure 3. In normal nonpregnant women, ICAM-1 was primarily localized to endothelial cells (Figure 3a). In normal pregnant women, ICAM-1 was primarily on the endothelium, with some on the vascular smooth muscle (Figure 3b). In women with preeclampsia, ICAM-1 was present not only on the endothelium but also on the vascular smooth muscle. Serial sections of a patient with preeclampsia are shown in Figure 3c to 3f with staining for IgG as negative control (Figure 3c), factor VIII (Figure 3d), ICAM-1 (Figure 3e), and
-smooth muscle actin (Figure 3f) demonstrating intense diffuse staining of ICAM-1 in the vascular smooth muscle. Figure 3g shows another example of ICAM-1 staining of the vascular smooth muscle verified by staining for
-smooth muscle actin in Figure 3h.
|
To verify specificity of the CD66b antigen for neutrophils, leukocytes were isolated from blood by histopaque density centrifugation. Neutrophils showed intense staining for CD66b, whereas monocytes and lymphocytes did not stain.
The percentage of vessels stained for CD66b was significantly greater for patients with preeclampsia than normal pregnant or normal nonpregnant patients (Figure 4a). There was also greater adherence and flattening of neutrophils along the endothelium (Figure 4b) and greater infiltration into the intima (Figure 4c). The total number of neutrophils adhered to endothelium and infiltrated into intima per stained vessel was greater for patients with preeclampsia (Figure 4d).
|
Representative sections of vessels for CD66b staining of neutrophils are shown in Figure 5. There was no staining for IgM-negative controls (data not shown). Few vessels for normal nonpregnant (Figure 5a) and normal pregnant patients (Figure 5b) had staining for CD66b except for occasional staining of neutrophils in the lumen or lightly attached to the endothelium. Stained neutrophils in normal nonpregnant and normal pregnant patients were generally rounded and it was rare to find neutrophils flattened to endothelium or infiltrated into the intima. In contrast, there was massive neutrophil involvement of vessels of women with preeclampsia with neutrophil adherence and flattening onto endothelium and infiltration into the intima. In some cases, vessels were almost occluded with neutrophils (Figure 5c through 5h).
|
| Discussion |
|---|
|
|
|---|
ICAM-1 was expressed on the endothelium in all groups. Endothelial ICAM-1 expression appeared to be downregulated in normal pregnancy. The most notable observation for ICAM-1 was that in patients with preeclampsia, ICAM-1 was expressed intensely on vascular smooth muscle. This corroborates the IL-8 data that there is inflammation of vascular smooth muscle in preeclampsia, because ICAM-1 is expressed by a variety of tissues under conditions of inflammation.18 Other investigators have reported markers of systemic inflammation in women with preeclampsia.1922
The percentage of vessels stained for CD66b was significantly greater in women with preeclampsia than in normal pregnant or normal nonpregnant women. There were significantly more vessels with neutrophils adhered and flattened along the endothelium and within the intima in women with preeclampsia as compared with controls. The percentage of vessels with neutrophils present within different portions of the vessel correlated with an overall greater number of neutrophils per vessel. Diffuse vessel staining also was present in women with preeclampsia and, most likely, reflected secretion of CD66b from activated neutrophils or neutrophils undergoing apoptosis.
These new data may explain previous findings in preeclampsia. A study by Roggensack et al showed increased expression of nitrotyrosine, suggestive of peroxynitrite formation, a strong prooxidant, in the vasculature of women with preeclampsia.23 A simultaneous increase in the expression of endothelial nitric oxide synthase and a decrease in the expression of superoxide dismutase also were observed. Our findings may explain the source of superoxide for the formation of peroxynitrite, because the rapid interaction of neutrophil superoxide with endothelial nitric oxide in the presence of deficient superoxide dismutase would produce peroxynitrite. This would result in an endothelial deficiency of nitric oxide, which could result in increased vasomotor tone and hypertension. Our data, in conjunction with Roggensacks data, strongly suggest that there is localized systemic oxidative stress throughout the maternal vasculature, which would result in lipid peroxidation leading to vascular inflammation and dysfunction.
Perspectives
The present study is the first to our knowledge to show that there is vascular smooth muscle inflammation and neutrophil infiltration into maternal systemic vascular tissue in preeclampsia. Neutrophil infiltration could explain clinical symptoms of hypertension, proteinuria, and edema.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received February 2, 2004; first decision February 18, 2004; accepted April 21, 2004.
| References |
|---|
|
|
|---|
2. Luster AD. Chemokineschemotactic cytokines that mediate inflammation. N Engl J Med. 1998; 338: 436445.
3. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, III, Hauth JC, Wenstrom KD. Williams Obstetrics. 21st ed. New York: McGraw-Hill; 2001.
4. Clark P, Boswell F, Greer IA. The neutrophil and preeclampsia. Semin Reprod Endocrinol. 1998; 16: 5764.[Medline] [Order article via Infotrieve]
5. Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol. 1998; 16: 93104.[Medline] [Order article via Infotrieve]
6. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999; 222: 222235.
7. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161: 12001204.[Medline] [Order article via Infotrieve]
8. Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989; 96: 978982.[Medline] [Order article via Infotrieve]
9. Tsukimori K, Maeda H, Ishida K, Nagata H, Koyanagi T, Nakano H. The superoxide generation of neutrophils in normal and preeclamptic pregnancies. Obstet Gynecol. 1993; 81: 536540.[Medline] [Order article via Infotrieve]
10. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998; 179: 8086.[CrossRef][Medline] [Order article via Infotrieve]
11. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E, Romero R. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001; 185: 792797.[CrossRef][Medline] [Order article via Infotrieve]
12. Barden A, Graham D, Beilin LJ, Ritchie J, Baker R, Walters BN, Michael CA. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci. 1997; 92: 3744.[Medline] [Order article via Infotrieve]
13. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregnancy. 1994; 13: 132.[CrossRef]
14. Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K, Videm V. Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension. 2002; 39: 155160.
15. Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest. 1998; 45: 229231.[CrossRef][Medline] [Order article via Infotrieve]
16. Conti P, Cifone MG, Alesse E, Reale M, Fieschi C, Dinarello CA. In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1. Prostaglandins. 1986; 32: 111115.[Medline] [Order article via Infotrieve]
17. Smart SJ, Casale TB. Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells. Am J Respir Cell Mol Biol. 1993; 9: 489495.[Medline] [Order article via Infotrieve]
18. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol. 1999; 66: 876888.[Abstract]
19. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998; 40: 102111.[Medline] [Order article via Infotrieve]
20. Granger JP, Alexander BT, Bennett WA, Khalil RA. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens. 2001; 14: 178S185S.[CrossRef][Medline] [Order article via Infotrieve]
21. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens. 2004; 17: 154160.[CrossRef][Medline] [Order article via Infotrieve]
22. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, OReilly GC, King IB, Zebelman AM, Luthy DA. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol. 1999; 149: 323329.
23. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999; 33: 8389.
This article has been cited by other articles:
![]() |
S. Verlohren, D. N. Muller, F. C. Luft, and R. Dechend Immunology in Hypertension, Preeclampsia, and Target-Organ Damage Hypertension, September 1, 2009; 54(3): 439 - 443. [Full Text] [PDF] |
||||
![]() |
S. W. Walsh Plasma From Preeclamptic Women Stimulates Transendothelial Migration of Neutrophils Reproductive Sciences, March 1, 2009; 16(3): 320 - 325. [Abstract] [PDF] |
||||
![]() |
Y. Gu, D. F. Lewis, K. Deere, L. J. Groome, and Y. Wang Elevated Maternal IL-16 Levels, Enhanced IL-16 Expressions in Endothelium and Leukocytes, and Increased IL-16 Production by Placental Trophoblasts in Women with Preeclampsia J. Immunol., September 15, 2008; 181(6): 4418 - 4422. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF] |
||||
![]() |
A. Tesse, F. Meziani, E. David, N. Carusio, H. Kremer, F. Schneider, and R. Andriantsitohaina Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H520 - H525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Walsh What Causes Endothelial Cell Activation in Preeclamptic Women? Am. J. Pathol., October 1, 2006; 169(4): 1104 - 1106. [Full Text] [PDF] |
||||
![]() |
F. Meziani, A. Tesse, E. David, M. C. Martinez, R. Wangesteen, F. Schneider, and R. Andriantsitohaina Shed Membrane Particles from Preeclamptic Women Generate Vascular Wall Inflammation and Blunt Vascular Contractility Am. J. Pathol., October 1, 2006; 169(4): 1473 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Leik and S. W. Walsh Systemic Activation and Vascular Infiltration of Neutrophils With Term Labor Reproductive Sciences, September 1, 2006; 13(6): 425 - 429. [Abstract] [PDF] |
||||
![]() |
O. Krysiak, A. Bretschneider, E. Zhong, J. Webb, H. Hopp, S. Verlohren, N. Fuhr, M. Lanowska, A. Nonnenmacher, R. Vetter, et al. Soluble Vascular Endothelial Growth Factor Receptor-1 (sFLT-1) Mediates Downregulation of FLT-1 and Prevents Activated Neutrophils From Women With Preeclampsia From Additional Migration by VEGF Circ. Res., December 9, 2005; 97(12): 1253 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Leik and S. W. Walsh Linoleic Acid, but not Oleic Acid, Upregulates Production of Interleukin-8 by Human Vascular Smooth Muscle Cells via Arachidonic Acid Metabolites Under Conditions of Oxidative Stress Reproductive Sciences, December 1, 2005; 12(8): 593 - 598. [Abstract] [PDF] |
||||
![]() |
R. B. Donker, G. Molema, M. M. Faas, C. G.M. Kallenberg, M. G. van Pampus, A. Timmer, and J. G. Aarnoudse Absence of In Vivo Generalized Pro-Inflammatory Endothelial Activation in Severe, Early-Onset Preeclampsia Reproductive Sciences, October 1, 2005; 12(7): 518 - 528. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |